SKK
CNCE

Shepherd Kaplan Krochuk’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-15,002
Closed -$282K – 442
2015
Q3 		$282K Hold
15,002
– – 0.08% 191
2015
Q2 		$223K Hold
15,002
– – 0.04% 280
2015
Q1 		$227K Hold
15,002
– – 0.04% 274
2014
Q4 		$200K Hold
15,002
– – 0.03% 347
2014
Q3 		$189K Buy
+15,002
New +$146K 0.02% 444

Other funds holding CNCE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Shepherd Kaplan Krochuk's CNCE Position: Q4 2015 in Review

Shepherd Kaplan Krochuk sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2015, closing a stake of 15,002 shares — an estimated $282K sold.

Shepherd Kaplan Krochuk first reported a position in CNCE in Q3 2014 and held it in 5 quarters. The position peaked at $282K in Q3 2015. 93 funds tracked by Wall St. Rank hold CNCE as of Q4 2015.

  • Shepherd Kaplan Krochuk reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 15,002 Concert Pharmaceuticals, Inc. shares in Q4 2015, an estimated $282K.
  • Shepherd Kaplan Krochuk first reported a position in Concert Pharmaceuticals, Inc. in Q3 2014 and held it in 5 quarters.
  • Shepherd Kaplan Krochuk's Concert Pharmaceuticals, Inc. position peaked at $282K in Q3 2015.
  • 93 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q4 2015, filed 16 Feb 2016.